Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethical Issues01:27

Ethical Issues

1.1K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.1K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Ethical Dilemmas II01:30

Ethical Dilemmas II

1.3K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.3K
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

4.1K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
4.1K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

230
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
230
Global Regulatory Systems01:28

Global Regulatory Systems

66
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel <i>GPRC5B</i>::<i>PRKCA</i> gene fusion in an unclassifiable low-grade glioneuronal tumor.

Neuro-oncology advances·2026
Same author

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Cancer science·2026
Same author

Two cases of durvalumab-induced Evans syndrome in biliary tract cancer.

Clinical journal of gastroenterology·2026
Same author

Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2026
Same author

A nationwide survey of medical resource usage for cancer treatment using Japanese health claims data from 2011 to 2022.

Scientific reports·2026

Related Experiment Video

Updated: Aug 27, 2025

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
11:00

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI

Published on: March 19, 2021

4.6K

[Expert Panel Issues in Japan].

Manabu Muto1

  • 1Dept. of Clinical Oncology, Kyoto University Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 26, 2022
PubMed
Summary

Cancer genomic medicine in Japan is increasing the burden on expert panels due to reimbursement rules and limited hospital access. This paper discusses challenges and future directions for these crucial panels.

Area of Science:

  • Oncology
  • Genomics
  • Healthcare Management

Background:

  • The implementation of cancer genomic medicine in Japan is expanding rapidly.
  • Expert panels are essential for guiding treatment decisions in genomic medicine.
  • Increasing demand has led to a significant rise in the workload for these panels.

Purpose of the Study:

  • To describe the challenges faced by expert panels in cancer genomic medicine in Japan.
  • To discuss the future outlook for expert panels based on hospital experiences.
  • To identify factors contributing to the increased burden on these panels.

Main Methods:

  • Analysis of hospital experiences with expert panels in cancer genomic medicine.
  • Review of factors influencing the workload of expert panels.

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 27, 2025

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
11:00

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI

Published on: March 19, 2021

4.6K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

1.1K
  • Discussion of current challenges and future strategies.

    • Main Results:

    • The burden on expert panels is increasing due to factors like reimbursement policies.
    • The concentration of panels at core hospitals exacerbates the workload.
    • Implementation challenges require strategic solutions for panel sustainability.

    Conclusions:

    • Addressing the challenges faced by expert panels is crucial for the effective implementation of cancer genomic medicine.
    • Future strategies should focus on optimizing panel function and accessibility.
    • Sustainable solutions are needed to support the growing demands of genomic medicine.